Delivery Order SPE2DB20D3303-SPE2DB25FA3AW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors with a ceiling value of $16,289.67 under firm fixed-price terms. The contract is set to be completed by August 6, 2025, with the place of performance located in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,702.33 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injectors. This firm fixed price, non-set-aside delivery order is scheduled for completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,097.54 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,237.99 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections on August 1, 2025, with completion scheduled for August 4, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract utilizes no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $14,661.49 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injectors on July 23, 2025. This firm fixed-price delivery order is non-competitive and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with completion scheduled for July 24, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors, with a ceiling value of $46,729.78 under firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 14, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $24,402.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on August 21, 2025, with completion scheduled for August 22, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The award was made...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors with a ceiling value of $16,361.85. This firm fixed-price contract, which expires August 21, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation, and performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $6,706.07. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 prime vendor agreement through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $9,408.12 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitive, non-set-aside contract reflects firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3AWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,791.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999.9 million through December 2026. The contract involves no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The DLA Pharmaceutical Prime Vendor Global Program serves as the contracting vehicle through which AmerisourceBergen fulfills medical supply requirements for customers including the Defense Health Agency and U.S. Coast Guard. Zepbound (tirzepatide), a diabetes and weight-management medication, reflects the company's role in supporting military healthcare needs across multiple therapeutic domains through its expansive federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.8k | 8/27/25 |